Roundtable-Supported Drug Pricing Legislation Passes Senate

On July 23, the Senate unanimously voted to pass the Affordable Prescriptions for Patients Act (S. 1041). The bill aims to address “patent thickets,” a strategy that pharmaceutical companies use to overlap patents on a single drug, which blocks competition and keeps drug prices high. This bill, which has broad bipartisan support, limits the number of patents a drug company can place on a single product. The legislation is expected to encourage innovation, allow generics to enter the market, and help prevent prescription costs from rising further. The Public Sector HealthCare Roundtable has been a leading supporter of the Affordable Prescriptions for Patients Act for many years and will closely monitor the legislation as it moves on to the House.